UCB BIOPHARMA SPRL
Patent Owner
Stats
- 153 US PATENTS IN FORCE
- 33 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 153 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,841 Total Citation Count
- Aug 20, 2002 Earliest Filing
- 13 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0068,406 METHOD OF GENERATING, STORING AND MINING DATA RELATED TO KEY OPINION LEADERS IN SCIENTIFIC FIELDS AND COMPUTER SYSTEM CONFIGURED FOR PRESENTING AN EXPLORABLE GRAPHICAL USER INTERFACESep 07, 16Mar 08, 18[G06Q, G06F]
2018/0044,416 Polymeric Fc proteins and methods of screening to alter their functional characteristicsMar 04, 16Feb 15, 18[G01N, C07K]
2018/0037,646 EPITOPES OF IL-17A AND IL-17F AND ANTIBODIES SPECIFIC THERETOSep 07, 17Feb 08, 18[C07K]
2017/0242,959 METHOD AND SYSTEM FOR QUANTIFYING THE LIKELIHOOD THAT A GENE IS CASUALLY LINKED TO A DISEASEFeb 24, 16Aug 24, 17[G06F]
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0090,415 METHODS TO PRODUCE PARTICLES COMPRISING THERAPEUTIC PROTEINSAbandonedMay 21, 14Mar 31, 16[A61K, C07K]
2014/0276,568 SYSTEMS AND METHODS FOR DAMPENING FRICTION IN AN AUTOINJECTOR DEVICEAbandonedMar 15, 13Sep 18, 14[G09B, A61M]
2014/0044,732 Nucleic Acids Encoding Antibody Molecules Which Bind IL-17A and IL-17FAbandonedSep 24, 13Feb 13, 14[C07K]
7632856 Indolone derivatives, processes for preparing them and their usesExpiredJul 14, 05Dec 15, 09[A61K, C07D]
2007/0148,172 Method for the treatment of inflammatory bowel diseaseAbandonedNov 03, 04Jun 28, 07[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.